Hartford Investment Management Co. trimmed its holdings in shares of CME Group Inc (NASDAQ:CME) by 26.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 39,758 shares of the financial services provider’s stock after selling 14,112 shares during the period. Hartford Investment Management Co.’s holdings in CME Group were worth $7,717,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of CME. Royal Bank of Scotland Group PLC grew its holdings in CME Group by 1.3% during the second quarter. Royal Bank of Scotland Group PLC now owns 75,702 shares of the financial services provider’s stock valued at $14,695,000 after purchasing an additional 960 shares during the last quarter. Arizona State Retirement System grew its holdings in CME Group by 1.1% during the second quarter. Arizona State Retirement System now owns 127,055 shares of the financial services provider’s stock valued at $24,663,000 after purchasing an additional 1,357 shares during the last quarter. Squar Milner Financial Services LLC acquired a new position in CME Group during the second quarter valued at approximately $186,000. Mitchell Capital Management Co. grew its holdings in CME Group by 22.7% during the second quarter. Mitchell Capital Management Co. now owns 7,331 shares of the financial services provider’s stock valued at $1,423,000 after purchasing an additional 1,354 shares during the last quarter. Finally, Manning & Napier Group LLC grew its holdings in CME Group by 13.7% during the second quarter. Manning & Napier Group LLC now owns 426,430 shares of the financial services provider’s stock valued at $82,773,000 after purchasing an additional 51,235 shares during the last quarter. 85.72% of the stock is currently owned by institutional investors.
In other CME Group news, Director Dennis Suskind sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $212.46, for a total value of $318,690.00. Following the sale, the director now owns 4,853 shares in the company, valued at approximately $1,031,068.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel R. Glickman sold 500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total value of $108,005.00. Following the sale, the director now owns 14,593 shares in the company, valued at approximately $3,152,233.93. The disclosure for this sale can be found here. Insiders have sold a total of 76,771 shares of company stock valued at $15,398,375 over the last 90 days. Corporate insiders own 1.20% of the company’s stock.Several equities analysts have commented on the company. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 9th. Citigroup set a $202.00 price objective on shares of CME Group and gave the stock a “buy” rating in a research note on Thursday, May 2nd. ValuEngine upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a research note on Monday, May 27th. Finally, Deutsche Bank lifted their price target on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $194.00.
CME stock traded down $0.46 during midday trading on Wednesday, reaching $215.76. The stock had a trading volume of 690,651 shares, compared to its average volume of 1,581,974. The business has a fifty day simple moving average of $207.88 and a two-hundred day simple moving average of $188.20. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The firm has a market cap of $75.64 billion, a price-to-earnings ratio of 31.64, a PEG ratio of 4.70 and a beta of 0.23. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $217.65.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company’s revenue was up 20.1% on a year-over-year basis. During the same period last year, the company earned $1.74 earnings per share. On average, equities analysts predict that CME Group Inc will post 6.68 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.39%. CME Group’s payout ratio is currently 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.